0001410578-19-001170.txt : 20190911 0001410578-19-001170.hdr.sgml : 20190911 20190911090050 ACCESSION NUMBER: 0001410578-19-001170 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20190909 ITEM INFORMATION: Other Events FILED AS OF DATE: 20190911 DATE AS OF CHANGE: 20190911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 191087218 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 8-K 1 tv529198_8k.htm FORM 8-K
0001131324 false 0001131324 2019-09-08 2019-09-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

united states

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 9, 2019

 

GENOMIC HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or Other Jurisdiction of
Incorporation)

000-51541

(Commission File Number)

77-0552594

(I.R.S. Employer
Identification No.)

 

301 Penobscot Drive  
Redwood City, California 94063
(Address of principal executive offices) (Zip Code)

 

(650) 556-9300

(Registrant’s telephone number,
including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

xWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol(s)  Name of each exchange on which registered
Common Stock, par value $0.0001 per share GHDX The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§240.12b–2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 8.01 Other Events.

 

As previously disclosed, on July 28, 2019, Genomic Health, Inc., a Delaware corporation (“Genomic Health”), entered into an Agreement and Plan of Merger with Exact Sciences Corporation, a Delaware corporation (“Exact Sciences”), and Spring Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Exact Sciences (“Merger Sub”), pursuant to which Merger Sub will merge with and into Genomic Health, with Genomic Health surviving as a wholly owned subsidiary of Exact Sciences (the “Merger”).

 

The completion of the Merger is conditioned upon expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) relating to the consummation of the Merger. The applicable waiting period under the HSR Act expired at 11:59 p.m., Eastern time, on September 9, 2019.

 

The completion of the Merger remains subject to other customary closing conditions, including approval of the Merger by Genomic Health stockholders.

 

*         *         *

 

Additional Information

 

In connection with the proposed transaction, Exact Sciences has filed with the Securities and Exchange Commission (“SEC”) a registration statement on Form S-4, which includes a preliminary prospectus of Exact Sciences and a preliminary proxy statement of Genomic Health (the “proxy statement/prospectus”), and each party will file other documents regarding the proposed transaction with the SEC. The registration statement has not yet become effective and the proxy statement/prospectus included therein is in preliminary form. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. A definitive proxy statement/prospectus will be sent to Genomic Health’s stockholders when it becomes available. Investors and security holders may obtain the registration statement and the proxy statement/prospectus free of charge from the SEC’s website (https://www.sec.gov) or from Exact Sciences or Genomic Health when it becomes available. The documents filed by Exact Sciences with the SEC may be obtained free of charge at Exact Sciences’ website at www.exactsciences.com or at the SEC’s website at www.sec.gov. These documents may also be obtained free of charge from Exact Sciences by requesting them by mail at Exact Sciences Corporation, 441 Charmany Drive, Madison, Wisconsin 53719, or by telephone at (608) 535-8815. The documents filed by Genomic Health with the SEC may be obtained free of charge at Genomic Health’s website at www.genomichealth.com or at the SEC’s website at www.sec.gov. These documents may also be obtained free of charge from Genomic Health by requesting them by mail at Genomic Health, Inc., 301 Penobscot Drive, Redwood City, California 94063, or by telephone at (650) 556-9300.

 

Participants in the Solicitation

 

Exact Sciences, Genomic Health and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information about Exact Sciences’ directors and executive officers is available in Exact Sciences’ proxy statement for its 2019 Annual Meeting of Stockholders, which was filed with the SEC on April 30, 2019, and Exact Sciences’ Current Report on Form 8-K, which was filed with the SEC on July 26, 2019. Information about Genomic Health’s directors and executive officers is available in Genomic Health’s proxy statement for its 2019 Annual Meeting of Stockholders, which was filed with the SEC on April 25, 2019, and Genomic Health’s Annual Report on Form 10-K for the year ended December 31, 2018, which was filed with the SEC on February 28, 2019. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are or will be contained in the registration statement, the proxy statement/prospectus and other relevant materials filed or to be filed with the SEC regarding the proposed transaction. Stockholders, potential investors and other readers should read the proxy statement/prospectus carefully before making any voting or investment decisions. You may obtain free copies of these documents from Exact Sciences or Genomic Health as indicated above.

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933.

 

 2 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 10, 2019

 

  GENOMIC HEALTH, INC.
   
   
  By:   /s/ Jason W. Radford
    Jason W. Radford
    Chief Legal Officer

 

 

EX-101.SCH 2 ghdx-20190909.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 ghdx-20190909_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 ghdx-20190909_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Cover
Sep. 09, 2019
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 09, 2019
Entity File Number 000-51541
Entity Registrant Name GENOMIC HEALTH, INC.
Entity Central Index Key 0001131324
Entity Tax Identification Number 77-0552594
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 301 Penobscot Drive
Entity Address, City or Town Redwood City
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94063
City Area Code (650)
Local Phone Number 556-9300
Written Communications true
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol GHDX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( !A(*T\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ &$@K3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " 82"M/G8J3@.X K @ $0 &1O8U!R;W!S+V-O M&ULS9+/:L,P#(=?9?B>R&[8(";-I66G#08K;.QF;+4UC?]@:R1]^R59 MFS*V!]C1TL^?/H$:':4."5]2B)C(8KX;7.>SU''-CD11 F1]1*=R.2;\V-R' MY!2-SW2 J/1)'1!6G#^ 0U)&D8()6,2%R-K&:*D3*@KI@C=ZP2621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( !A(*T_?.KU&G ( )0+ 8 >&PO=V]R:W-H965T&ULA5;MCILP$'P5Q ,M?HGV&9FQV8R\A8/(5]5Q;F.WMJF4[NXTKK?)HDZ5;QEZDGTO#-O M+D*V3)NIO":JEYR=':EM$IJFRZ1E=1>7A5L[R+(0-]W4'3_(2-W:ELD_>]Z( MQRXF\?O"2WVMM%U(RJ)G5_Z=ZQ_]09I9,E4YURWO5"VZ2/+++OY MGN:6X)# M_*SY0\W&D3W*48A7._ERWL6IW1%O^$G;$LP\[OR9-XVM9/;Q>RP:3YJ6.!^_ M5__D#F\.Q]&97]BMT2_B\9F/!UK$T7CZK_S.&P.W.S$: M)]$H]QN=;DJ+=JQBMM*RM^%9=^[Y&-[D^4C#"70DT'\$ZLXR"+F=?V2:E844 MCT@.'[]GUF.RI>;;G.RB^Q3NG=F\,JOW,BV2NRTS(O8#@LX09$(DIO8D0%$! MZNC9C$YQ>H;2,T?/9_3,VQ]$Y+A C@KD@+[P!"!BB0LL4($%H*\\ 8A8XP)+ M5& )Z!M/ ")(BBNL4(45Y!-/ H$$?%ZC$FO(]XU&( &G-ZC$!O)]JQ%(P&N2 MXG%*807?;@P3,)P$0DM@!=]S!$,#IA,\N83""K[M&";@.\$#3F!^J>\\A@E8 M3_"4$QABZIN/84+NXU$G,,D4N(]@0N[C>2/ )C'66^R(0$Q"A>/(I3'7F_\,03$@$#SZ%H?(A>WWWM@F%#W@0>?PE#GU%?Y_PV?S/HIVZ]^ M8_):=RHZ"FU:,]= 7830W)1+GTS"*],B3Y.&7[0=KLQ8#GWB,-&B'WO@9&K$ MR[]02P,$% @ &$@K3T7CQ;U= @ 8 !0 !X;"]S:&%R9613=')I M;F=S+GAM;(54WV_:,!!^[OZ*$]I#*P%Q@- Q4:0HI"UJ2UE!VK1I#\8QQ%IB M9[9#X;_?!;1JBLGZEOB^^^Z^^S4VQL(^SZ2Y::76%I\]S["4Y]1T5<$E6C9* MY]3BK]YZIM"<)B;EW.:9UR-DZ.54R!:44OPN>:1*:6]:@WYK,C9B,K:32.VX M'GMV,O:JA]/CDA==(*,V](@_JAN/'O C7!NK*;,_Z_:I8F7.I875H>!UXZ?. M0_TI1'!R=+C-Z+9NW=#,."QO(19<"Y5 +!.84NO@CCI&[0\7%^>$Q-(*>X!; MD7&8E_G:K0,AI!/XP/JO@VS>=1M M8(I0C:89S&3"]_# #V=2\?V^W^\-&AA6= ^S!&G$1C!JA9(-HJZO.R0(>L&H MB6DFF=*%TD>2-BPM5A:4AN/P:,Q5)6Y'X@:R,$DT-Z;]]P,>A>3P+!V&/O&Q MG5*M#5,6IEKL'$B=,JK^,+&5>I5U[ M/7A6.1H5YC^=-X4*KG9#,"1R%[U$L ME+'8ON^B.%N>T8 ,^P[KD0'W]:S+Y3 @5_7'1\4PRB)5LFED@V#8&?4)J;]_ MU<):+C%4GN,M.$V(J:.L+MTE4IE@P@JYA2>LDQ8TJT,6FG<8$G.LW6GU<:7Q M2#QO-FZ&#GAF3(G@__FLA,4E51OP>Y?K*UAR5NHSC:W$X=POK6*_VE!0#3N: ME1P^DFZU/U @OTFI=C2N-$TJ@;5JTIJ/Q'E(>G?_('4$L#!!0 ( !A(*T^ZH3F* MUP$ #(& - >&POC" M@J"RL.?!U[2=MH'<3*?'=G^]2=/;T0?QX(.^-#/?3+[YGTP!07FA:9'M23 MPIY49M"8TQ-E1=88O2-W- (^E2L@%RYS^LBE*)V8<[D2BF0 MTR0@_6L,)]$+*A<>);1Q 62Q0OR62_I/@=7KO2NDW 2F- )%9CDB./WDG3EY M!G\)D<4^3]8K;!V?DO2>[A/FP1S'A13MK_Z_O,M_HI@MW7-HT:L&W5!2#D*BT(O&3M0U1'GAA_GUM#P0>)S6/$HQ:#>S@7WOT3Q M U!+ P04 " 82"M/, /WOC?GE]F)>%\1[;,O:YPO51="/\US7W=@M;^C'IQ46F*K@Z2\RWW/H!O? 01K M\G%13'*KT:GY;.!:AM094Y;*-6"CL!1L2Q8-1?U07RY2LIXBE+@53-* M\@9-#;3HH'D3&B^XG%JO.8LA\8SO'T:/8NG!F(5@[^Z5=.*/',/WS'\ 4$L# M!!0 ( !A(*T__P"8(O0 (4" : >&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'.MDD$*@S 0 +\B>4!7;>FAJ*=>O+;]0-#5B)J$[);J[YMZ44&A M!R\)8LX'LQYT4,CQT>7S%1]_27 M6<]>@C"MA[_)1/TUP.K795]02P,$% @ &$@K3PN/V ,A 0 5P0 !, M !;0V]N=&5N=%]4>7!E&ULM51-3\,P#/TK4Z]HS># 6V[ %>8!'\@ M)&X;-5^RO=']>]QN0V(J8FC;)8GS[/=>$BOS]VT&FG3!1UH4#7-^4(I, T%3 MF3)$0:J$0;.$6*NL3:MK4'>SV;TR*3)$GG+/42SG3U#IM>?)XVZ_IUX4.F?O MC&:7HMI$>T0ZW1.6"'[(H<9ENI&$8O+<"0O)WJ(0E IU@L)Q81]+W>L&$)V% M?UE+5>4,V&3604I*R@C:4@/ P9?4: 3[QNABO?>[TL@O.@BQZKSZD5!>SP=O M/8P;&)!+*K.T!8Q)#PGPG;83UVX=\@J6$Z[];_:'29RZ!=_,W(1TKM05\-_\GR"U!+ 0(4 M Q0 ( !A(*T\?(\\#P !," + " 0 !?D !D;V-0&UL4$L! A0#% @ &$@K3YV*DX#N M *P( !$ ( !F0$ &1O8U!R;W!S+V-O&UL4$L! M A0#% @ &$@K3YE&PO=V]R:W-H965T&UL4$L! M A0#% @ &$@K3T7CQ;U= @ 8 !0 ( !R0L 'AL M+W-H87)E9%-T&UL4$L! A0#% @ &$@K3[JA.8K7 0 ,@8 M T ( !6 X 'AL+W-T>6QE&PO=V]R:V)O;VLN M>&UL4$L! A0#% @ &$@K3__ )@B] A0( !H ( ! MOA$ 'AL+U]R96QS+W=O XML 8 tv529198_8k_htm.xml IDEA: XBRL DOCUMENT 0001131324 2019-09-08 2019-09-09 iso4217:USD shares iso4217:USD shares 0001131324 false 8-K 2019-09-09 GENOMIC HEALTH, INC. DE 000-51541 77-0552594 301 Penobscot Drive Redwood City CA 94063 (650) 556-9300 true false false false Common Stock, par value $0.0001 per share GHDX NASDAQ false XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 1 97 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://genomichealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tv529198_8k.htm ghdx-20190909.xsd ghdx-20190909_lab.xml ghdx-20190909_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tv529198_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "tv529198_8k.htm" ] }, "labelLink": { "local": [ "ghdx-20190909_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "ghdx-20190909_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "ghdx-20190909.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 57, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ghdx", "nsuri": "http://genomichealth.com/20190909", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "tv529198_8k.htm", "contextRef": "From2019-09-08to2019-09-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://genomichealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "tv529198_8k.htm", "contextRef": "From2019-09-08to2019-09-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r9" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://genomichealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r11": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r12": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r13": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r14": { "Name": "Forms 20-F, 40-F", "Number": "249", "Publisher": "SEC", "Section": "220 and 240", "Subsection": "f" }, "r15": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r18": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" } }, "version": "2.1" } ZIP 13 0001410578-19-001170-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-19-001170-xbrl.zip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end